Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness

The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...

Полное описание

Библиографические подробности

Главные авторы:	Elina Järvinen, Markus Holmberg, Marja-Liisa Sumelahti
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2016-09-01
Серии:	Neurology International
Предметы:	Relapsing remitting multiple sclerosis DMA efficacy long term use switch
Online-ссылка:	http://www.pagepress.org/journals/index.php/ni/article/view/6513
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!